Obinutuzumab (anti-CD20)Obinutuzumab (anti-CD20)
Move your mouse over image or click to enlarge

Obinutuzumab (anti-CD20)

Obinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD.
Cat# Size Price Qty Buy
A2023-5mg 5mg £801.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2023

Related Documents